Optimapharm
ActiveSummary
Optimapharm has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €96,701 and a net result of €92,091. Equity is growing by about 61% per year across the filed financial years. Its solvency ranks better than 34% of 2,990 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Directors
Directors
1 director, last change in 2024
Mirna Šenjug Novak
CurrentDirector · since 23-11-2023
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
6 of this company's 7 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
2 people since 2023, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Mirna Šenjug Novak |
|
| Martina Okun Šola |
|
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.